The common claim in the lawsuits is that a contaminant in Zantac (ranitidine) called N-nitrosodimethylamine (NDMA) – as well as other ranitidine products – increased the risk of cancer.
The company has agreed to pay $2.2 billion to settle around 80,000 state court product liability cases alleging injury from Zantac (ranitidine), most of which had been consolidated in a Delaware ...
His oral medications prior to admission included topiramate 100 mg twice daily, ranitidine hydrochloride 75 mg twice daily, ferrous sulfate 325 mg twice daily, potassium chloride 10 meq once daily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback